We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Ginseng Helps Cancer Patients Fight Fatigue

By HospiMedica International staff writers
Posted on 20 Jun 2012
High doses of American ginseng (Panax quinquefolius) over two months appears to counteract the fatigue often associated with cancer, according to a new study.

Researchers at the Mayo Clinic Cancer Center (Rochester, MN, USA) conducted a study that included 364 cancer patients at 40 sites who reported at least moderate fatigue--a score of 4 or more on a 10-point fatigue scale--for which other causes like anemia, pain, and insomnia could be ruled out. More...
The participants received double-blind treatment with 2,000 mg of ground Wisconsin ginseng root taken as two capsules separately before noon, or with placebo, for a period of eight weeks.

The results showed that fatigue scores among cancer patients dropped 20%, compared with 10.3% on placebo pills. The effect was already noticeable at four weeks, when the ginseng group scores improved by 14.4 points on the 100-point scale, compared with an 8.2-point improvement in the placebo group. The most common side effects reported on ginseng over the eight weeks were a 5% rate of nausea compared with about 4% in the placebo group, and a roughly 4% rate of loose stool, versus 3% with placebo. The study was presented at the American Society of Clinical Oncology annual meeting, held during June 2012 in Chicago (IL, USA).

“Cancer is a prolonged chronic stress experience and the effects can last 10 years beyond diagnosis and treatment,” said lead author and study presenter Debra Barton RN, PhD. “If we can help the body be better modulated throughout treatment with the use of ginseng, we may be able to prevent severe long-term fatigue.”

Fatigue in cancer patients has been linked to an increase in the immune system's inflammatory cytokines, as well as poorly regulated levels of the stress-hormone cortisol. Ginseng, used in traditional Chinese medicine (TCM) as a natural energy booster, possesses active ingredients called ginsenosides that have been shown (in animal studies) to reduce cytokines related to inflammation and help regulate cortisol levels.

Related Links:

Mayo Clinic Cancer Center




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.